U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT07492199) titled 'High Depth Exome Sequencing on DNA From a Salivary Sample by Mouth Smear.' on March 19.
Brief Summary: Despite technological advances, a genetic etiology has been identified in only about 50% to 60% of patients with Neurodevelopmental disorders (NDDs), with a higher diagnostic yield in the syndromic NDD and IDD subgroups. However, identifying a precise etiological diagnosis is essential to optimize patient care, clarify their prognosis, consider targeted therapies, refer families to appropriate resources and support, and provide genetic counseling to relatives. The tests typically offered as part of the etiological assessment of sy...